Siemens Healthineers in Canada, in partnership with Sunnybrook Health Sciences Centre and Sunnybrook Research Institute, is launching a Healthcare Transformation Program — an immersive four-day experience focused on “Screening for Preclinical Alzheimer’s in the Era of Disease Modifying Therapies (DMTs)” for shaping the healthcare systems of tomorrow.
As DMTs shift the Alzheimer’s landscape toward earlier detection and intervention, participants will explore how technology, workflow transformation, and clinical innovation can redesign screening pathways across the Canadian healthcare system.
We invite the Canadian research and clinical community—along with Sunnybrook Health Sciences Centre staff—to an exclusive program dedicated to advancing early detection and evolving care pathways for Alzheimer’s disease as disease-modifying therapies (DMTs) emerge.
Date: May 29, May 30, June 5, and June 6 (consecutive Fridays and Saturdays)
Venue: Harrison Hall EG 21, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON M4N 3M5
All participants will receive an e-certificate of participation. The top 3 prizes* will be awarded:
- 1st place team total of $600,
- 2nd place team total of $300,
- 3rd place team total of $150.
Key Topics that will be discovered:
- Innovations in diagnostic imaging & digital biomarkers
- The changing landscape of Alzheimer’s screening & preclinical detection
- Workflow optimization for earlier detection & triage
- Preparing institutions for DMT readiness
- Commercialization and implementation strategies for healthcare innovation
Deadline to Apply: May 22, 2026
Shortlisted participants will be contacted directly by May 25, 2026
Program
Day 1 | Framing the Challenge
Friday, May 29, 2026
- Align on the Alzheimer’s screening and DMT-readiness problem space
- Learn key clinical, operational, and system-level context
- Form multidisciplinary teams with clearly defined focus areas
Day 2 | Systems & stakeholders, barriers & ethical considerations
Saturday, May 30, 2026
- Map the current diagnostic and screening ecosystem
- Analyze real-world constraints and care pathways
- Conduct stakeholder and assumption analysis with expert mentor guidance
- Identify and stress-test bottlenecks, risks and ethical dilemma
- Draft the top system and organizational roadblocks
Day 3 | Impact and innovation development
Saturday, June 5, 2026
- Consider implications for equity, access, and resource allocation
- Evaluate clinical, human, and system-level outcomes
- Outline best, likely, and unintended consequences
- Refine concepts into a structured final innovation brief
Day 4 | Outcome exhibition and celebration
Saturday, June 6, 2026
Participants will leave with:
- A deep understanding of Alzheimer’s DMT-driven innovation needs
- Hands-on experience with healthcare innovation methodologies
- Actionable concepts and pathways for transforming screening and early detection
- Strengthened skills in entrepreneurship, commercialization, and system analysis
Want to learn more about our products and services?
Click the cards below to explore.
